Integra LifeSciences (NASDAQ:IART) Issues FY23 Earnings Guidance

Integra LifeSciences (NASDAQ:IART – Get Free Report) updated its FY23 earnings guidance on Thursday. The company provided EPS guidance of $3.10-3.18 for the period, compared to the consensus EPS estimate of $3.13. The company issued revenue guidance of $1.55-1.56 billion, compared to the consensus revenue estimate of $1.56 billion. Integra LifeSciences also updated its FY […]

Related Keywords

Integra Lifesciences ,Covestor Ltd ,Securities Exchange Commission ,Topco Ltd ,Neuberger Berman Group ,Citigroup ,Integra Lifesciences Company Profile ,Integra Lifesciences Holdings Corporation ,Get Free Report ,Exchange Commission ,Financial Advisors ,Berman Group ,Lifesciences Holdings Corporation ,Codman Specialty Surgical ,Integra Lifesciences Daily ,Nasdaq Iart ,Tiart ,Medical ,45798520 ,Guidance ,Earnings ,Preannouncement ,